EMMAC
is a biotechnology company that researches, develops, and commercializes medical cannabis products for the medical sector... Read moreEMMAC
is a biotechnology company that researches, develops, and commercializes medical cannabis products for the medical sector... Read more
News
Jul 06, 2021
MarketScreener
EMMAC: Curaleaf International : Secures Complete GMP Certification of Second EU GMP Facility in Europe
Apr 27, 2021
MarketScreener
EMMAC: Novel Foods CBD Products Validation from the Foods Standards Agency
Apr 07, 2021
Cision Canada
Press Release: EMMAC : Curaleaf Completes Acquisition of EMMAC and Secures US$130 Million Investment from a Single Strategic Institutional Investor
Apr 07, 2021
New Cannabis Ventures
EMMAC: Curaleaf Raises $130 Million to Fund Cash Closing Costs and Future Expenses of International Acquisition
Apr 07, 2021
FE Investegate
EMMAC: FastForward Inn Ltd : Completion of Sale of Investment in EMMAC
Mar 30, 2021
FE Investegate
EMMAC: EMMAC Life Sciences : EMMAC launch first Medical Cannabis Flower for UK
Mar 17, 2021
FE Investegate
EMMAC: Chrystal Cptl Prtnrs : EMMAC Life Sciences is acquired by Curaleaf
Mar 11, 2021
News Break
EMMAC: Curaleaf CEO Touts Potential of European Cannabis Market on Back of $286M Acquisition | News Break
Mar 11, 2021
Markets Insider
EMMAC: Yooma Completes Acquisition of Wellness Brands from EMMAC Life Sciences Group
Mar 10, 2021
CFN Media Group
EMMAC: Curaleaf to Enter European Cannabis Market with Acquisition of EMMAC Life Sciences Limited - Europe's Leading Independent Cannabis Company
